Updated 20:03 GMT, 5 Nov 2026 SPX 7,400.37 -3.75% NDX 26,906.42 -5.38% VIX 24.13 +45.27% GOLD 4,127.00 +1.33% CL 90.56 +2.77% BTC 76,158.55 -5.28%
NAS100 26,906 −5.38% S&P 7,400 −3.75% GOLD $4,127 +1.33% BTC $76,159 −5.28% VIX 24.13 +45.27% prices · as of 20:03 UTC
Vol. II · No. 309Thursday, 5 November 2026
TTitan Protect
Case Studies · Earnings Echo

A 37% Margin of Safety Meets CVS Health’s Print

Filed Wednesday 4 November 2026 · 13:18 UTC · Entry no. 133971 · scored against the close · never edited

A 37% Margin of Safety Meets CVS Health’s Print
Earnings Preview · 04 November 2026
Where our screen stands going in
Screens compliant (on our anchor standard; the faith-based screen is stricter here). A name values-conscious investors can weigh on the merits.
What the Street expects
Consensus looks for earnings of about $1.65 a share on revenue near $104.7B. Over the next twelve months analysts pencil in $8.54 of earnings per share against $3.80 over the last twelve, growth of about 125%. The median analyst target is $113 (range $103 to $145), 28% above the $88.50 share price, across 25 analysts.
How it has traded on past prints
Across the last 25 reports, the shares moved an average of +0.4% in the five sessions after the print and -0.3% over twenty. After a beat the average follow-through was +0.3%; after a miss, -8.0%. There is no reliable drift pattern: the first move has often faded, so chasing the gap has not paid.
Levels that matter
At $88.50 the shares sit 20% below the 52-week high of $110.68 and 27% above the low of $69.51 (46% of the way up the range). The 50-day average is $91.61, above the price. The 200-day average is $88.26, below the price.
Valuation going in
Our fair-value work puts the shares about 37% below what the business is worth: value on offer. Our fair-value estimate is $141.25 against the current share price of $88.50. The shares trade at 23.8 times trailing earnings and 10.6 times forward earnings. Revenue is growing about 7% with net margins near 1%.
Our stance
The name clears our screen; the print tells us whether the valuation is earning its keep.
What the flow says going in
Underlying money flow is neutral (21-day Chaikin Money Flow +0.04, five-day price change +0.3%, as of 2026-11-03, desk flow model): no strong accumulation or distribution signature.

This is analysis, not financial advice. Always manage your risk.

How This Entry Scores

Every level named in a session brief is scored against the next scheduled close. Nothing is edited after filing: if a level breaks, the record shows it as filed, not as corrected. The desk's full scored history sits on the track record page.

Continue Reading View all Case Studies →
Membership

The ledger is public. The desk behind it is not.

Membership opens every room and every entry the day it is filed, with the same dated honesty the record is built on.

Join the desk

This is analysis, not financial advice. Always manage your risk.

Get our weekly market brief free.